Abbott Laboratories
ABT
115,89 €
Prix de l'action
0.44%
Changement (1 jour)
17.80%
Changement (1 an)
Catégories
Abbott Laboratories (ABT) - Dette totale
Dette totale au bilan au Mars 2025 : 11.53 Milliards d'euros
Selon les derniers rapports financiers d'Abbott Laboratories, la dette totale de l'entreprise est de 11.53 Milliards d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.
Abbott Laboratories - Dette totale au bilan (de 1996 à 2025)
Dette totale par année
| Année | Dette totale | Changement |
|---|---|---|
| 2024-12-31 | €14.43 Md | 2.11% |
| 2023-12-31 | €14.13 Md | -14.4% |
| 2022-12-31 | €16.51 Md | -1.59% |
| 2021-12-31 | €16.78 Md | 5.05% |
| 2020-12-31 | €15.97 Md | -5.28% |
| 2019-12-31 | €16.86 Md | -1.39% |
| 2018-12-31 | €17.10 Md | -26.51% |
| 2017-12-31 | €23.27 Md | 11.24% |
| 2016-12-31 | €20.92 Md | 154.14% |
| 2015-12-31 | €8.23 Md | 27.87% |
| 2014-12-31 | €6.43 Md | 35.51% |
| 2013-12-31 | €4.75 Md | -69.31% |
| 2012-12-31 | €15.47 Md | 30.41% |
| 2011-12-31 | €11.86 Md | -16.55% |
| 2010-12-31 | €14.22 Md | 23.83% |
| 2009-12-31 | €11.48 Md | 40.3% |
| 2008-12-31 | €8.18 Md | -2.13% |
| 2007-12-31 | €8.36 Md | -11.07% |
| 2006-12-31 | €9.40 Md | 67.97% |
| 2005-12-31 | €5.59 Md | 12.03% |
| 2004-12-31 | €4.99 Md | 5.07% |
| 2003-12-31 | €4.75 Md | -22.57% |
| 2002-12-31 | €6.14 Md | -25.56% |
| 2001-12-31 | €8.25 Md | 399.74% |
| 2000-12-31 | €1.65 Md | -25.58% |
| 1999-12-31 | €2.21 Md | -15.02% |
| 1998-12-31 | €2.61 Md | 13.95% |
| 1997-12-31 | €2.29 Md | 17.39% |
| 1996-12-31 | €1.95 Md |
Dette totale pour des entreprises similaires ou concurrentes
| Entreprise | Dette totale/th> | Dette totale différencediff. | Pays |
|---|---|---|---|
 Johnson & Johnson JNJ | €45.53 Md | 294.59% | 🇺🇸 USA |
 Pfizer PFE | €53.40 Md | 362.85% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | €29.79 Md | 158.19% | 🇺🇸 USA |
 Hologic HOLX | €2.20 Md | -80.89% | 🇺🇸 USA |
 Medtronic MDT | €23.18 Md | 100.93% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | €44.64 Md | 286.94% | 🇺🇸 USA |
 Boston Scientific BSX | €10.20 Md | -11.58% | 🇺🇸 USA |
 AstraZeneca AZN | €27.26 Md | 136.32% | 🇬🇧 UK |
 Novartis NVS | €27.24 Md | 136.14% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | €20.78 Md | 80.09% | 🇬🇧 UK |